Egetis Therapeutics AB (publ) (LON:0ABW)

Egetis Therapeutics AB Revenue

Egetis Therapeutics AB had revenue of 17.40M SEK in the quarter ending September 30, 2025, with 85.11% growth. This brings the company's revenue in the last twelve months to 55.40M, down -18.41% year-over-year. In the year 2024, Egetis Therapeutics AB had annual revenue of 46.10M, down -19.97%.

• Revenue (ttm): 55.40M SEK
• Revenue Growth: -18.41%
• P/S Ratio: 37.42
• Revenue / Employee: 1.39M SEK
• Employees: 40
• Market Cap: 163.66M GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	46.10M	-11.50M	-19.97%
Dec 31, 2023	57.60M	35.00M	154.87%
Dec 31, 2022	22.60M	-15.60M	-40.84%
Dec 31, 2021	38.20M	-2.46M	-6.05%
Dec 31, 2020	40.66M	-41.90M	-50.75%